| 英文别名 |
BLU-554;BLU 554;Fisogatinib;BLU554;N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide;Fisogatinib [INN];fisogatinib (proposed INN);5Q7R99CKV2;BLU 554 [WHO-DD];GTPL10220;MGZKYOAQVGSSGC-DLBZAZTESA-N;N-((3S,4S)-3-((6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide;CS3008;s8503;N-[(3S,;N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl]amino]tetrahydro-2H-pyran-4-yl]-2-propenamide;NSC795718;AS-55934;X-439161;SCHEMBL16668287;CCG-269714;BDBM50575072;BLU111362;CS-5986;BLU554(Fisogatinib)?;X439161;DA-71570;N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino]oxan-4-yl]prop-2-enamide;FISOGATINIB [WHO-DD];WHO 10947;D11737;C24H24Cl2N4O4;CHEMBL4514636;N-[(3S,4S)-3-{[6-(2,6-Dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino}oxan-4-yl]prop-2-enamide;HY-100492;Fisogatinib [USAN];Fisogatinib (USAN/INN);MFCD30496704;EX-A841;BB160379;2-Propenamide, N-((3S,4S)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2H-pyran-4-yl)-;UNII-5Q7R99CKV2;Q29209801;GLXC-10936;1707289-21-1;Fisogatinib [USAN:INN];NSC-795718;BLU-111362;BLU554(Fisogatinib);AC-29871;AKOS030632994 |